Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer
Published in: Breast Cancer 4/2005

01-10-2005

Pathophysiology of seroma in breast cancer

Authors: Katsumasa Kuroi, Kojiro Shimozuma, Tetsuya Taguchi, Hirohisa Imai, Hiroyasu Yamashiro, Shozo Ohsumi, Shinya Saito

Published in: Breast Cancer | Issue 4/2005

Login to get access
Metadata
Title
Pathophysiology of seroma in breast cancer
Authors
Katsumasa Kuroi
Kojiro Shimozuma
Tetsuya Taguchi
Hirohisa Imai
Hiroyasu Yamashiro
Shozo Ohsumi
Shinya Saito
Publication date
01-10-2005
Publisher
Springer-Verlag
Published in
Breast Cancer / Issue 4/2005
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.2325/jbcs.12.288

Other articles of this Issue 4/2005

Breast Cancer 4/2005 Go to the issue

ReviewPaper

Diagnostic assessment of nonpalpable breast cancer-the difference in diagnostic approach for the clinical treatment of breast cancer between the japanese guidelines and the national comprehensive cancer network (USA) guidelines

ReviewPaper

Ultrasound (US) diagnosis of nonpalpable breast cancer

Report

Nodular pseudoangiomatous stromal hyperplasia of mammary stroma in a case showing rapid tumor growth

Report

Synchronous liver metastases of intracystic papillary carcinoma with invasion of the breast

ReviewPaper

Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients - evaluation of appropriate research design and methodology to measure symptoms

OriginalPaper

Her-2/neu expression in locally advanced breast carcinomas: pre- and post-neoadjuvant chemotherapy
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits